Summary
This fellowship will provide a prolific researcher with an internationally competitive, multi-disciplinary research training at the Chemistry/Biology interface in an EU leading Bioinorganic chemistry team, preparing her to obtain her goal of a faculty position in the EU and her own research team in Medicinal Chemistry.
She will develop novel anti-Alzheimer conjugates that target multiple disease's hallmarks. Afterwards she will evaluate their in vitro therapeutic and diagnostic potential through a secondment with cell biologists in another EU country, the United Kingdom.
This research will pave the way towards the development of innovative and effective anti-Alzheimer drugs by using versatile drug combination approaches to fight this horrible and still incurable disease.
Alongside her research she will also acquire research management, leadership, presentation and teaching skills to prepare her for a successful future as an independent research group leader.
She will develop novel anti-Alzheimer conjugates that target multiple disease's hallmarks. Afterwards she will evaluate their in vitro therapeutic and diagnostic potential through a secondment with cell biologists in another EU country, the United Kingdom.
This research will pave the way towards the development of innovative and effective anti-Alzheimer drugs by using versatile drug combination approaches to fight this horrible and still incurable disease.
Alongside her research she will also acquire research management, leadership, presentation and teaching skills to prepare her for a successful future as an independent research group leader.
Unfold all
/
Fold all
More information & hyperlinks
| Web resources: | https://cordis.europa.eu/project/id/656820 |
| Start date: | 01-01-2016 |
| End date: | 22-04-2018 |
| Total budget - Public funding: | 170 121,60 Euro - 170 121,00 Euro |
Cordis data
Original description
This fellowship will provide a prolific researcher with an internationally competitive, multi-disciplinary research training at the Chemistry/Biology interface in an EU leading Bioinorganic chemistry team, preparing her to obtain her goal of a faculty position in the EU and her own research team in Medicinal Chemistry.She will develop novel anti-Alzheimer conjugates that target multiple disease's hallmarks. Afterwards she will evaluate their in vitro therapeutic and diagnostic potential through a secondment with cell biologists in another EU country, the United Kingdom.
This research will pave the way towards the development of innovative and effective anti-Alzheimer drugs by using versatile drug combination approaches to fight this horrible and still incurable disease.
Alongside her research she will also acquire research management, leadership, presentation and teaching skills to prepare her for a successful future as an independent research group leader.
Status
CLOSEDCall topic
MSCA-IF-2014-EFUpdate Date
28-04-2024
Geographical location(s)
Structured mapping
Unfold all
/
Fold all
